Immunization recommendations for travel in the Mediterranean area;Reisemedizinische impfempfehlungen für den Mittelmeerraum

Wiener Klinische Wochenschrift

Volumn 116, Issue 19-20, 2004, Pages 652-660

  Rendi Wagner, Pamela ^a   Hoeller, Kurt ^a   Kollaritsch, Herwig ^a   Bauer, B ^b   Burgmann, H ^b   Dieberger, H ^b   Gruber, C ^b   Haditsch, M ^b   Harbich, H ^b   Holzmann, H ^b   Jeschko, E ^b   Kunze, M ^b   Laferl, H ^b   Marth, E ^b   Most J ^b   Neuman, B ^b   Pichler, H ^b   Prinz, A ^b   Sommer, H ^b   Stemberger, H ^b   Stemberger, R ^b   Wenisch, C ^b   Wernsdorfer, W H ^b   Wiedermann, G ^b   Wiedermann, U ^b   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Mediterranean; Travel medicine; Vaccinations

Indexed keywords

ALBANIA; BOSNIA AND HERZEGOVINA; CROATIA; EGYPT; EPIDEMIC MENINGITIS; FRANCE; GREECE; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNIZATION; IMMUNOPROPHYLAXIS; INFECTION; INFECTION RISK; ITALY; MOROCCO; PORTUGAL; PUBLIC HEALTH SERVICE; RABIES; REVIEW; SLOVENIA; SOUTHERN EUROPE; SPAIN; TICK BORNE ENCEPHALITIS; TOURISM; TRAVEL; TUNISIA; TURKEY (REPUBLIC); TYPHOID FEVER; WORLD HEALTH ORGANIZATION; YUGOSLAVIA;

ANIMALS; COMMUNICABLE DISEASE CONTROL; CROSS-CULTURAL COMPARISON; ENCEPHALITIS, TICK-BORNE; EUROPE; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; MEDITERRANEAN REGION; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; PRACTICE GUIDELINES; RABIES; RICKETTSIAL VACCINES; SEROEPIDEMIOLOGIC STUDIES; TRAVEL; TYPHOID FEVER; VACCINATION; VIRAL VACCINES;

EID: 8744252740     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-004-0252-4     Document Type: Review

References (44)

1. Bundesministerium für Gesundheit und Frauen. Jahresausweise über angezeigte übertragbare Krankheiten. www. bmgf.gv.at
2. Van Herck K, Van Damme P, Castelli F, Zuckerman J, Nothdurft H, Dahlgren AL, et al (2004) Knowledge, attitudes and practices in travel-related infectious diseases: the European Airport Survey. J Travel Med 11: 3-8
3. Papaevangelou G (1992) Epidemiology of hepatitis A in Mediterranean countries. Vaccine 10 [Suppl]: 63-66
4. Steffen R (2004) Epidemiologie Reisemedizinisch relevanter Infektionen mit Leberbeteiligung. 9. Linzer Reisemedizinische Tagung, 20.3.2004, Linz, Austria
5. Divizia M, Gabrieli R, Stefanoni ML, et al (1999) HAV and HEV infection in hospitalised hepatitis patients in Alexandria, Egypt. Eur J Epidemiol 15: 603
6. Mele A, Rosmini F, Zampieri A, Gill ON (1986) Integrated epidemiological system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results. SEIEVA Collaborating Group. Eur J Epidemiol 2: 300-304
7. Mele A, Stroffolini T, Palumbo F, et al (1997) Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. SEIEVA Collaborating Group. J Hepatol 26: 743-747
8. Castelli F, Carosi G, Tebaldi A, et al (1996) Age-specific anti-hepatitis a virus seroepidemiology in Italian travelers: indications for anti-hepatitis a vaccination. J Travel Med 3: 214-218
9. Divizia M, Ruscio V, Degener AM, Pana A (1998) Hepatitis A virus detection in wastewater by PCR and hybridization. New Microbiol 21: 161-167
10. Yapicioglu H, Alhan E, Yildizdas D, Yaman A, Bozdemir N (2002) Prevalence of hepatitis a in children and adolescents in Adana, Turkey. Indian Peadiatrics 39: 936-941
11. Kanra G, Tezcan S, Badur S; Turkish National Study Team (2002) Hepatitis A seroprevalence in a random sample of the turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr 44: 204-210
12. Papaevangelou G, Roumeliotou-Karayannis A, Contoyannis P (1982) Changing epidemiological characteristics of acute viral hepatitis in Greece. Infection 10: 1-4
13. Lionis C, Frangoulis E, Koulentakis M, Biziagos E, Kouroumalis E (1997) Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, Greece. Eur J Epidemiol 13: 417-420
14. Puntariæ D, Bozikov J, Vodopija R (1996) Cost-benefit analysis of general immunization against hepatitis A in Croatia. Croatian Medical Journal 37: 3
15. Marinho RT, Valente AR, Ramalho FJ, de Moura MC (1997) The changing epidemiological pattern of hepatitis A in Lisbon, Portugal. Eur J Gastroenterol Hepatol 9: 795-797
16. Barros H, Oliveira F, Miranda H (1999) A survey on hepatitis A in Portuguese children and adolescents. J Viral Hepat 6: 249-253
17. Coursaget P, Leboulleux D, Gharbi Y, et al (1995) Etiology of acute sporadic hepatitis in adults in Senegal and Tunisia. Scand J Infect Dis 27: 9-11
18. Sherif MM, Abou-Aita BA, Abou-Elew MH, el-Kafrawi AO (1985) Hepatitis B virus infection in upper and lower Egypt. J Med Virol 15: 129-135
19. El-Sayed NM, Gomatos PJ, Rodier GR, et al (1996) Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt. Am J Trop Med Hyg 55: 179-184
20. Pasquini P, Kahn HA, Pileggi D, Pana A, Terzi J, Guzzanti E (1983) Prevalence of hepatitis B markers in Italy. Am J Epidemiol 118: 699-709
21. Giusti G, Gaeta GB, Russo M, Bedarida G (1989) HBsAg carriers among blood donors in Italy - a multicentre study in 107 blood banks. Infection 17: 237-239
22. Sidal M, Unuvar E, Oguz F, Cihan C, Onel D, Badur S (2001) Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey. Eur J Epidemiol 17: 141-144
23. Nas T, Taner MZ, Yildiz A (1999) Seroprevalence of syphilis, human immunodeficiency virus type-1, and hepatitis B virus infections among pregnant women in Turkey. Int J Gyn Obst 66: 171-172
24. Chironna M, Germinario C, Lopalco PL, et al (2003) Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey. Infection 31: 70-74
25. Kyriakis KP, Foudoulaki LE, Papoulia EI, Sofroniadou KE (2000) Seroprevalence of hepatitis B surface antigen (HBs-Ag) among first-time and sporadic blood donors in Greece: 1991-1996. Transfus Med 10: 175-180
26. Sypsa V, Hadjipaschali E, Hatzakis A (2001) Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees. Eur J Epidemiol 17: 721-728
27. Jelic O, Jelic D, Balen I, et al (1994) Prevalence of markers of hepatitis B virus infection among the general population of the municipality of Slavonski Brod. Acta Med Croatica 48: 111-116
28. Goudeau A, Dubois F (1995) Incidence and prevalence of hepatitis B in France. Vaccine 13 [Suppl]: 22-25
29. Dominguez A, Bruguera M, Vidal J, Plans P, Salleras L (2000) Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996. Vaccine 18: 2345-2350
30. Santos A, Carvalho A, Tomaz J, et al (2000) Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra. Acta Med Port 13: 167-171
31. Heikel J, Sekkat S, Bouqdir F, et al (1999) The prevalence of sexually transmitted pathogens in patients presenting to a Casablanca STD clinic. Eur J Epidemiol 15: 711-715
32. Andre F (2000) Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 18 [Suppl 1]: 20-22
33. Triki H (1994) Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 91: 11-14
34. Bennish ML (1995) Immunization against Salmonella typhi. Infect Dis Clin Pract 4: 114-122
35. Steffen R (1993) Hepatitis A and hepatitis B: risks compared with other vaccine preventable diseases and immunization recommendations. Vaccine 11: 518-520
36. Stroffolini T, Manzillo G, De Sena R, et al (1992) Typhoid fever in the Neapolitan area: a case-control study. Eur J Epidemiol 8: 539-542
37. Consenus-Papier der Initiative Meningokokken. www. gruenes-kreuz.org/ infektionen
38. Lévy-Bruhl D, Perrocheau A, Mora M, et al (2002) Vaccination campaign following an increase in incidence of serogroup C meninigococcal diseases in the department of Puy-de-Dôme. Eurosurveillance Monthly 7: 74-76
39. Girgis NI, Sippel JE, Kilpatrick ME, et al (1993) Meningitis and encephalitis at the Abassia Fever Hospital, Cairo, Egypt, from 1966 to 1989. Am J Trop Med Hyg 48: 97-107
40. Rotivel Y, Goudal M, Simons de Fanti A (2003) Human rabies prophylactics: the French experience. Vaccine 21: 710-715
41. Sacks JJ, Kresnow M, Houston B (1996) Dog bites: how big a problem? Inj Prev 2: 52-4
42. Lontai I (1997) The current state of rabies prevention in Europe. Vaccine 15: 16-19
43. Rendi-Wagner P (2004) Risk and prevention of tick-borne encephalitis in travelers. J Travel Med (in press)
44. Robert Koch-Institut (2003) Epidemiologische Bulletin Nr 7